Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 50 for:    Elotuzumab

A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02718833
Recruitment Status : Active, not recruiting
First Posted : March 24, 2016
Last Update Posted : March 20, 2019
Sponsor:
Collaborators:
Celgene
Bristol-Myers Squibb
Multiple Myeloma Research Consortium
Information provided by (Responsible Party):
Andrew Yee, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2019
  Estimated Study Completion Date : September 2023